The effect of Inofolic Supplement on infertility treatment in women with polycystic ovarian syndrome

Evaluating the effect of combination of Inofolic Supplement and Klomifen and Klomifen alone on infertility treatment in women with polycystic ovarian syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190825044605N1

Enrollment

Registered

2019-09-27

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: Patients in the intervention group will be given clomiphene and inofolic supplement for 3 months. In the first month of the intervention, 50 mg clomiphene is admin

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age range of 20 to 40 years old Infertile women with polycystic ovarian syndrome

Exclusion criteria

Exclusion criteria: Ovarian surgery history in the past three months Use of antiepileptic drugs and glucocorticoids Congenital adrenal hyperplasia Hypothyroidism Hyperthyroidism

Design outcomes

Primary

Measure	Time frame
The number of developed follicles. Timepoint: Two weeks after the intervention. Method of measurement: Using Sonography.;The number of clinical pregnancies. Timepoint: Third week after intervention. Method of measurement: Based on Beta-HCG and ultrasound confirmation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Ebrahimpour

Sanandaj University of Medical Sciences

k.ebeahimpour@muk.ac.ir+98 87 3366 4673

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026